Our finding of high overexpression of EZH2 in triple-negative DCIS as well as invasive breast carcinoma supports an important role of EZH2 in carcinogenesis of triple-negative breast carcinoma. The gene discussed is EZH2; the disease is triple-negative breast carcinoma.